🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/2022 | 77,26 | 79,81 | 77,26 | 78,88 | +2,43% | 3,30% | 17.447.900 |
| 04/01/2022 | 76,40 | 77,27 | 75,89 | 77,01 | +0,18% | 1,81% | 11.981.700 |
| 03/01/2022 | 76,58 | 76,94 | 75,35 | 76,87 | +0,30% | 2,08% | 9.441.200 |
| 31/12/2021 | 77,14 | 77,55 | 76,62 | 76,64 | -0,65% | 1,21% | 6.019.500 |
| 30/12/2021 | 77,12 | 77,61 | 76,97 | 77,14 | +0,25% | 0,83% | 5.859.100 |
| 29/12/2021 | 76,80 | 77,18 | 76,47 | 76,95 | +0,18% | 0,92% | 5.926.100 |
| 28/12/2021 | 76,68 | 77,14 | 76,21 | 76,81 | +0,31% | 1,21% | 5.727.100 |
| 27/12/2021 | 76,00 | 76,61 | 75,77 | 76,57 | +1,11% | 1,11% | 6.334.700 |
| 23/12/2021 | 76,30 | 76,30 | 75,35 | 75,73 | -0,56% | 1,25% | 9.894.900 |
| 22/12/2021 | 75,44 | 76,56 | 75,13 | 76,16 | +0,82% | 1,90% | 9.256.000 |
| 21/12/2021 | 76,25 | 76,28 | 74,89 | 75,54 | -1,14% | 1,82% | 14.947.800 |
| 20/12/2021 | 75,70 | 76,50 | 74,95 | 76,41 | +0,95% | 2,05% | 11.818.800 |
| 17/12/2021 | 76,56 | 77,74 | 75,50 | 75,69 | -0,29% | 2,93% | 28.040.600 |
| 16/12/2021 | 75,50 | 76,53 | 75,27 | 75,91 | +0,82% | 1,67% | 16.601.700 |
| 15/12/2021 | 73,71 | 75,39 | 73,71 | 75,29 | +2,13% | 2,28% | 14.263.400 |
| 14/12/2021 | 72,36 | 74,04 | 72,16 | 73,72 | +0,41% | 2,60% | 18.949.700 |
| 13/12/2021 | 72,37 | 73,45 | 71,97 | 73,42 | +1,10% | 2,05% | 17.486.100 |
| 10/12/2021 | 73,12 | 73,23 | 72,25 | 72,62 | -0,33% | 1,34% | 11.398.800 |
| 09/12/2021 | 73,44 | 73,56 | 72,69 | 72,86 | -0,48% | 1,18% | 11.938.000 |
| 08/12/2021 | 72,54 | 73,41 | 72,08 | 73,21 | +1,29% | 1,83% | 14.331.400 |
| 07/12/2021 | 72,03 | 72,72 | 71,50 | 72,28 | -1,55% | 1,69% | 17.635.100 |
| 06/12/2021 | 73,30 | 73,85 | 72,80 | 73,42 | +0,11% | 1,43% | 13.506.800 |
| 03/12/2021 | 74,09 | 74,25 | 72,66 | 73,34 | -0,74% | 2,15% | 14.508.900 |
| 02/12/2021 | 74,38 | 74,78 | 73,30 | 73,89 | -0,74% | 1,99% | 15.345.300 |
| 01/12/2021 | 75,53 | 76,91 | 74,39 | 74,44 | -0,63% | 3,34% | 21.435.900 |
| 30/11/2021 | 74,75 | 75,03 | 73,84 | 74,91 | +0,03% | 1,59% | 30.179.900 |
| 29/11/2021 | 76,42 | 77,50 | 74,00 | 74,89 | -5,39% | 4,58% | 34.192.400 |
| 26/11/2021 | 78,73 | 79,93 | 77,11 | 79,16 | -3,79% | 3,58% | 18.022.000 |
| 24/11/2021 | 82,80 | 82,90 | 81,96 | 82,28 | -0,63% | 1,14% | 8.537.000 |
| 23/11/2021 | 81,49 | 83,59 | 81,34 | 82,80 | +1,42% | 2,76% | 12.130.800 |